| Literature DB >> 16612335 |
C Licht1, S Heinen, M Józsi, I Löschmann, R E Saunders, S J Perkins, R Waldherr, C Skerka, M Kirschfink, B Hoppe, P F Zipfel.
Abstract
We report a novel pathomechanism for membranoproliferative glomerulonephritis type II (MPGN II) caused by a mutant Factor H protein expressed in the plasma. Genetic analyses of two patients revealed deletion of a single Lys residue (K224) located within the complement regulatory region in domain 4 of Factor H. This deletion resulted in defective complement control: mutant protein purified from the plasma of patients showed severely reduced cofactor and decay-accelerating activity, as well as reduced binding to the central complement component C3b. However, cell-binding activity of the mutant protein was normal and comparable to wild-type Factor H. The patients are daughters of consanguineous parents. As both patients but also their healthy mother were positive for C3 nephritic factor, the mutant Factor H protein is considered relevant for unrestricted activation of the disease-causing activation of the alternative complement pathway. Replacement of functional Factor H by fresh frozen plasma (10-15 ml/kg/14 days) was well tolerated, prevented so far disease progression in both patients, and is in the long run expected to preserve kidney function.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16612335 DOI: 10.1038/sj.ki.5000269
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612